Asterias Biotherapeutics, Inc. (AST)

[tradetrak]

AST is neither "long running" nor a failure. You want to short it that's your business, but anyone who's been following the science, taking note of the partners, and recognizes a great opportunity when they see one, isn't going to get suckered in by rehashed ancient history. Could it go to hell in a hand basket? Yeah, but there's NOTHING in this trash article that's got me shaking in my boots. The PHI, as is typical, was a safety study and had no efficacy related endpoints. The PHII that's in enrollment now will be the telling tale.